Initial safety experience of abciximab and heparin for acute ischemic stroke

Cerebrovasc Dis. 2005;19(4):276-8. doi: 10.1159/000084371. Epub 2004 May 28.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Abciximab
  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Brain Ischemia / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Heparin / administration & dosage*
  • Heparin / adverse effects
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Immunoglobulin Fab Fragments / adverse effects
  • Male
  • Middle Aged
  • Stroke / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Heparin
  • Abciximab